Aggressive policies that target the use and promotion of off-label use are needed to prevent the use of drugs for non-approved indications with little benefit or with harmful outcomes. It should be ...

Should the federal government punish companies for telling the truth? Of course not. But the Food and Drug Administration (FDA) does it all the time. Consider a recent federal court case involving ...

In a recent national survey, a substantial minority of physicians erroneously believed that certain off-label uses of prescription drugs were approved by the Food and Drug Administration. This ...

The majority of patients prescribed antipsychotic medications in state Medicaid programs are taking these agents for off-label indications. Continuously enrolled patients with at least 1 prescription ...

Doctors often prescribe antidepressants to tackle conditions like migraine headaches for which they aren’t technically approved. Now, researchers say such “off-label” usage mostly occurs without clear ...

The Food and Drug Administration (FDA) authorizes the marketing of drugs only for uses that the manufacturer has demonstrated to be safe and effective. However, the FDA does not regulate medical ...

Testing for Discordance at Metastatic Relapse: Does It Matter? Off-label drug use refers to the prescription of licensed drugs for clinical indications or in a manner different from that approved by ...

Dabigatran has been readily integrated into clinical practice in the United States, primarily for treatment of atrial fibrillation (A-fib) but increasingly for off-label indications as well, according ...

The Food and Drug Administration has relaxed label requirements for taking the abortion-inducing mediation Mifeprex (mifepristone), a move that may make it easier to prescribe the drug in states that ...

The Food and Drug Administration (FDA) has approved new labeling for Naftin (naftifine HCl cream 2%; Merz Pharmaceuticals) adding additional information regarding use in the pediatric population. The ...

There’s a new name on the lips of everyone looking to shed their last five, 10, or even 25 pounds. That name is semaglutide. Then, on Monday, New York published a feature about how trendy Ozempic and ...